Name | C188-9 |
---|
Description | A novel small-molecule STAT3 inhibitor with Ki of 12.4 nM; inhibits STAT3 binding to its pY-peptide ligand, suppresses cytokine-stimulated pSTAT3, reduces constitutive pSTAT3 activity, and inhibits anchorage dependent and independent growth of in multiple HNSCC cell lines; prevents tumor xenograft growth, modulates many STAT3-regulated genes involved in oncogenesis and radioresistance in vivo. Solid Tumors Phase 1 Clinical |
---|---|
References | References 1. Redell MS, et al. Blood. 2011 May 26;117(21):5701-9. 2. Bharadwaj U, et al. Oncotarget. 2016 May 3;7(18):26307-30. 3. Jung KH, et al. Clin Cancer Res. 2017 Sep 15;23(18):5537-5546. 4. Minus MB, et al. Angew Chem Int Ed Engl. 2015 Oct 26;54(44):13085-9. View Related Products by Target STAT Solid Tumors |
Molecular Formula | C28H23NO4S |
---|---|
Molecular Weight | 469.555 |